CLINICAL_TRIALS
trial_result
· 2017-11-13
Clinical Trial Update: A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis [Phase 3]
Summary
A randomized, double-blind Phase 3 trial in Seborrheic Keratosis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Seborrheic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2017-11-13